Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Supplementary Mental Incisive Nerve Block and Buccal Infiltration to Improve Inferior Alveolar Nerve Block Success
IRCT20180513039638N2Phase 3Completed
- Sponsor
- Urmia University of Medical Sciences
- Start
- May 2021
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of ropivacaine in irreversible pulpitis, sponsored by Urmia University of Medical Sciences. Started May 2021; status: completed.
02
Drugs
ropivacaine
03
Conditions
irreversible pulpitis
Beyond the preview
Go deeper on IRCT20180513039638N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20180513039638N2.